Abstract:Background: Acute graft-versus-host disease (aGVHD) is a common complication after allogeneic hematopoietic cell transplantation (allo-HSCT), with high morbidity and mortality. Although glucocorticoids are the standard treatment, only half of patients achieve complete remission. Thus, there is an urgent need to screen biomarkers for the diagnosis of aGVHD to assist in the identification of individuals at risk of aGVHD. This study was to construct prediction models for the occurrence and severity of aGVHD using two machine learning algorithms based on serum biochemical data. Methods: Clinical data of 120 patients with hematological diseases who received allo-HSCT were retrospectively analyzed. Seventy-six patients developed aGVHD, including 56 grade I/II and 20 grade III/IV. First, 15 serum biochemical indicators were considered as potential risk factors, and the differences in the levels of indicators between non-aGVHD and aGVHD were observed, followed by evaluation of the diagnostic property. Subsequently, to develop the prediction models for the occurrence and severity of aGVHD, LASSO and random forest (RF) analyses were performed with experimental indicators. Finally, Venn diagram analysis was utilized to obtain shared biomarkers in the two algorithms to construct the nomogram. The model performance was measured by calibration curves. Internal and external validations were performed based on risk score models and ROC curve analyses. Results: Total 12 of 15 indicators exhibited significant differences between the aGVHD and non-aGVHD groups, with AUC values > 0.75. In machine learning analysis, eight features (LAG-3, TLR-2, PD-L1, IP-10, elafin, REG-3α, ST2, TIM3) and seven variables (LAG-3, TLR-2, PD-1, Flt_3, IL-9, elafin, TIM3) were selected to distinguish aGVHD vs. non-aGVHD as well as grade I/II vs. III/IV, respectively. Further, the corresponding nomogram models were established and calibration curves showed that prediction was in good agreement with the actual probability. Biomarker-based risk score model was constructed, which obtained AUC value >0.89 in internal and external datasets. Conclusion: Clinical variables screened through learning algorithm can predict the risk and severity of aGVHD. Our findings may help clinicians develop more personalized and reasonable management strategies.

The Predictive Value of Selected Serum Micrornas for Acute GVHD by TaqMan MicroRNA Arrays

Plasma Microrna-586 is a New Biomarker for Acute Graft-Versus-host Disease

MicroRNA‐181a, a Potential Diagnosis Marker, Alleviates Acute Graft Versus Host Disease by Regulating IFN‐γ Production

Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer

Dynamic Changes in Serum Cytokine Levels and Their Clinical Significance in Predicting Acute GVHD.

Diagnosis of Cutaneous Acute Graft‐Versus‐Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation

A panel of 4 biomarkers for the early diagnosis and therapeutic efficacy of aGVHD

miR-146a and miR-155 Expression Levels in Acute Graft-Versus-Host Disease Incidence

Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment

Two machine learning-derived nomogram for predicting the occurrence and severity of acute graft-versus-host disease: a retrospective study based on serum biomarkers

Mir-153-3p, a New Bio-Target, is Involved in the Pathogenesis of Acute Graft-Versus-host Disease Via Inhibition of Indoleamine- 2,3-Dioxygenase.

Application of CD25 and CTLA4 gene transcription levels in early prediction of acute graft-versus-host disease

[The relationship between cytokine mRNA expression level and acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation]

Soluble interleukin-27 receptor alpha is a valuable prognostic biomarker for acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation

Can Cytokine Detection Predict the Occurrence and Outcome of aGVHD after Allo-HCT? A Retrospective Study

Soluble interleukin-27 receptor alpha is a valuable predictive biomarker for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Cytokines are early diagnostic biomarkers of graft-versus-host disease in liver recipients

Circulating MicroRNA Panel As a Diagnostic Marker for Hepatocellular Carcinoma

Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants-single centre pilot study

Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading?

A gut microbiota score predicting acute graft‐versus‐host disease following myeloablative allogeneic hematopoietic stem cell transplantation